BCTX - Briacell Therapeutics Corp - Stock Forecast

Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

BCTX is currently covered by 1 analysts with an average price target of $18. This is a potential upside of $16.56 (1150%) from yesterday's end of day stock price of $1.44.

Briacell Therapeutics Corp's activity chart (see below) currently has 1 price targets and 6 ratings on display. The stock rating distribution of BCTX is 100% BUY.

Stock Analyst Price Targets - Review

Highest price target for BCTX is $18, Lowest price target is $18, average price target is $18.

Most recent stock forecast was given by EMILY BODNAR from HC WAINWRIGHT on 24-May-2024. First documented stock forecast 14-Feb-2022.

Best performing analysts who are covering BCTX - Briacell Therapeutics Corp:

Emily Bodnar

Currently out of the existing stock ratings of BCTX, 5 are a BUY (100%).

Analyst name


Current price target

Potential Upside

Previous price target


Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score



$16.56 (1150.00%)


2 days ago

0/6 (0%)

$16.56 (1150.00%)

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is BCTX (Briacell Therapeutics Corp) average time for price targets to be met?

On average it took 0 days on average for the stock forecasts to be realized with a an average price target met ratio 0

Which analyst has the current highest performing score on BCTX (Briacell Therapeutics Corp) with a proven track record?


Which analyst has the most public recommendations on BCTX (Briacell Therapeutics Corp)?

Emily Bodnar has 9 price targets and 8 ratings on BCTX

Which analyst is the currently most bullish on BCTX (Briacell Therapeutics Corp)?

Emily Bodnar with highest potential upside - $16.56

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?